← Back to Search

Device

BF-MP190F 3 mm ultrathin bronchoscope for Peripheral Pulmonary Nodules

N/A

Recruiting

Led By Alexander Chen, M.D.

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up receipt of cytology/histopathology results (approximately 7 days)

Awards & highlights

Study Summary

This trial is testing whether ultrathin bronchoscopes (3mm diameter) are better than conventional bronchoscopes (5 or 4mm diameter) at reaching and diagnosing peripheral lesions.

Eligible Conditions

Peripheral Pulmonary Nodules

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ receipt of cytology/histopathology results (approximately 7 days)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~receipt of cytology/histopathology results (approximately 7 days)

This trial's timeline: 3 weeks for screening, Varies for treatment, and receipt of cytology/histopathology results (approximately 7 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall diagnostic yield (concentric and eccentric lesions) for peripheral pulmonary nodules

Secondary outcome measures

Ability to successfully convert ultrasound images from eccentric to concentric view by exchanging the 4mm thin bronchoscope for the 3mm ultrathin bronchoscope

Diagnostic yield of bronchoscopy utilizing a 3mm bronchoscope for eccentric lesions

Incidence of related adverse events

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: BronchoscopyExperimental Treatment4 Interventions

The bronchoscopy procedure and use of both the thin and ultrathin bronchoscopes are considered standard of care and will be performed under moderate sedation in an outpatient bronchoscopy suite as part of each patient's clinical care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor

1,931 Previous Clinical Trials

2,299,629 Total Patients Enrolled

OlympusIndustry Sponsor

18 Previous Clinical Trials

3,195 Total Patients Enrolled

Alexander Chen, M.D.Principal InvestigatorWashington University School of Medicine

5 Previous Clinical Trials

182 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are actively engaged in this experiment?

"Affirmative. Information presented on clinicaltrials.gov indicates that this research is seeking volunteers; the post date was April 20th 2020, and it has been edited as recently as January 18th 2022. Currently 80 participants are needed at a single site."

Answered by AI

Is this medical trial currently open to participants?

"Yes, the clinicaltrials.gov website indicates that this medical study remains open for recruitment with a starting date of April 20th 2020 and its last update on January 18th 2022. The research requires 80 individuals from one trial site to participate in the experiment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions

2020. "Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04331587.